CHL1 is an inhibitory oncogene in many tumors, which is involved in the inhibition of cancer cell proliferation, epithelial–mesenchymal transition (EMT), and even chemotherapy resistance, like esophageal squamous cell carcinoma and renal carcinoma (37–40). This evidence concerns the gene CHL1 and esophageal squamous cell carcinoma.